In recent years, the popularity and efficacy of GLP-1 medications have surged, revolutionizing the way obesity and metabolic health are managed. According to NIQ, 14 million households are taking GLP-1 medication, and that number is set to double by 2030. However, the journey for GLP-1 users doesn't end with a prescription. To help mitigate some of the side effects that come along with these drugs, careful attention to food, vitamin and supplement intake is critical.

Dr. Alexandra Sowa, founder and CEO of SoWell Health, is a leading expert in obesity medicine, and author of The Ozempic Revolution, which addresses the holistic needs of GLP-1 users, offering practical solutions for navigating side effects, nutrition, and lifestyle changes.

I had the opportunity to interview Dr. Sowa when her book was released earlier this month about how retailers and brands can help GLP-1 users to find the products, information and support that they need as they make their way through the store.

Dr, Sowa will be part of a panel discussion at ECRM’s upcoming GLP-1, Weight Management, Nutrition & Vitamin Session next month in Chicago.

ECRM: Can you share a bit about your background as a physician specializing in obesity medicine and what inspired you to write The Ozempic Revolution?

Sowa: My interest in obesity medicine began before I even knew the field existed. I always wanted to work in preventive medicine, but much of my training at NYU and during my internal medicine residency focused on managing disease states after they had significantly progressed. Often, the advice we gave was simply, “You should lose weight,” which is incredibly challenging once serious diseases have set in.

When I discovered the field of obesity and metabolic health medicine, there was no turning back. For over a decade, I’ve dedicated my practice to helping patients manage weight and metabolic health. Initially, it felt a bit fringe—even though I’m board-certified, many people, including other doctors, weren’t familiar with these treatments. But the emergence of GLP-1 medications has completely transformed the conversation. These drugs address obesity as a disease, not a matter of willpower, and they’ve led to significant breakthroughs in prevention and treatment. Still, medications alone aren’t enough. Patients need guidance on nutrition, lifestyle changes, and behavioral support to truly thrive.

This gap inspired me to write The Ozempic Revolution. The book provides comprehensive advice for anyone using GLP-1 medications, from addressing side effects to optimizing nutrition. It’s designed to empower patients and ensure their success.

ECRM: What are some of the biggest challenges GLP-1 users face regarding nutrition and supplementation?

Sowa: Two primary challenges come to mind. First, most users experience gastrointestinal side effects, such as constipation, diarrhea, and nausea. These symptoms are tied to how GLP-1s work—slowing gastric emptying, regulating the pancreas, and influencing appetite. For example, slower gastric emptying often leads to constipation, making fiber supplementation essential. Nausea can occur when users eat too much or too little, so products designed to support hydration and manage nausea are crucial.

Second, fatigue is common because these medications suppress appetite and, inadvertently, thirst. Many users don’t realize they’re not consuming enough calories or staying hydrated, which exacerbates these symptoms. Adequate protein intake is vital, especially during the early stages when appetite suppression is strongest. Protein shakes and supplements are convenient and help maintain muscle mass, which can otherwise be lost during weight loss. Additionally, products that support on-the-go nutrition are critical, as users often find themselves unprepared when hunger or fatigue strikes.

Beyond these immediate challenges, there is a growing awareness of how critical micronutrient intake is for long-term health. GLP-1 users are at risk of nutrient deficiencies due to lower food intake, making multivitamins or tailored supplements a valuable addition to their regimen. Educating users on how to choose high-quality supplements and when to incorporate them can greatly enhance their experience.

ECRM: How can retailers better support GLP-1 users in addressing these challenges?

Sowa: Retailers have a unique opportunity to create a supportive shopping experience. A dedicated section for GLP-1 users would be an excellent start, featuring products like fiber supplements, electrolyte solutions, protein shakes, and nausea remedies. Clear labeling and educational materials can also help consumers make informed choices.

For instance, when someone fills a GLP-1 prescription, providing a “starter kit” with essential products and a guide on managing side effects would be incredibly helpful. Over time, retailers can expand this support to include whole food recommendations and meal prep ideas. This not only meets immediate needs but also fosters long-term loyalty among consumers.

Retailers can also partner with healthcare providers to ensure their offerings align with medical advice. Collaborations might include hosting in-store workshops or creating digital platforms for GLP-1 users to access recipes, tips, and resources. By fostering a holistic approach, retailers can position themselves as trusted allies in the consumer’s health journey.

ECRM: You’ve mentioned the importance of different phases—prep, titration, and maintenance—in a GLP-1 user’s journey. How do their needs evolve across these phases?

Sowa: In the prep phase, users are just getting started. This is an ideal time to educate them and ensure they have the tools they need, like fiber and electrolyte supplements. Taking time to prepare can reduce the likelihood of side effects and set them up for success.

The titration phase involves gradually increasing medication doses. This is when side effects are most likely to occur, so consistent support is crucial. Users need products that help manage symptoms and maintain nutrition as they adapt. Encouraging them to monitor their progress and adjust their intake accordingly can be a game-changer during this phase.

During the maintenance phase, users often face different challenges, like the return of appetite. This is when they need guidance on sustainable eating habits to avoid regaining weight. Supporting muscle building through protein intake and offering convenient, nutrient-dense food options are key. Encouraging physical activity and offering products that cater to an active lifestyle can also be beneficial.

ECRM: What advice would you give to a store associate helping a GLP-1 user?

Sowa: First, approach every interaction with empathy and respect. Many GLP-1 users have faced weight stigma and may feel vulnerable. Start by asking if they’ve discussed their nutrition and supplementation needs with their doctor. If not, explain the importance of hydration, protein intake, and managing gastrointestinal symptoms. Direct them to products that address these needs and encourage them to plan ahead with portable snacks and drinks.

It’s also helpful to educate them on how their needs might evolve over time. For instance, they may need more protein during maintenance or different supplements to address side effects during titration. Having these conversations can make a huge difference.

Associates can also play a key role in helping users navigate new product lines or sections in the store. By familiarizing themselves with the latest offerings and their benefits, they can offer tailored recommendations and build stronger customer relationships.

ECRM: What role do suppliers play in this evolving landscape?

Sowa: Suppliers have an incredible opportunity to innovate and create products tailored to GLP-1 users. These consumers are shifting away from overly sweet or artificial-tasting products, preferring whole, nutrient-dense options. Developing items that align with these preferences, such as protein-rich snacks and minimally processed foods, will resonate strongly.

Additionally, transparency and education are key. Suppliers should clearly communicate the benefits of their products and consider labeling that highlights their suitability for GLP-1 users. Collaboration with retailers to create dedicated sections or educational campaigns can further enhance the shopping experience.

Suppliers can also invest in research to better understand the evolving needs of GLP-1 users. Whether it’s identifying gaps in current offerings or predicting future trends, these insights can inform product development and drive meaningful innovation. Partnering with healthcare professionals to validate product claims and ensure safety will also enhance trust and credibility.

ECRM: Any closing thoughts on how we can better support this growing consumer base?

Sowa: It’s an exciting time to reimagine how we approach nutrition and wellness in retail. By prioritizing education, empathy, and tailored solutions, we can empower GLP-1 users to thrive. This isn’t just about selling products; it’s about fostering long-term health and creating a more inclusive, supportive environment for everyone. I’m optimistic about the innovations and collaborations we’ll see in the coming years.

As the GLP-1 user community grows, so does the opportunity to make meaningful impacts on their lives. By leveraging insights, embracing innovation, and maintaining a patient-centered focus, we can redefine what it means to support health and wellness in a retail setting. Together, we can help these consumers not just manage their medications but truly thrive in every aspect of their health journey.

Watch the full interview with Dr. Sowa here!